132 related articles for article (PubMed ID: 10207504)
1. Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults.
Hoeck HC; Jakobsen PE; Vestergaard P; Falhof J; Laurberg P
Growth Horm IGF Res; 1999 Feb; 9(1):18-24. PubMed ID: 10207504
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
Hoeck HC; Vestergaard P; Jakobsen PE; Falhof J; Laurberg P
J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
[TBL] [Abstract][Full Text] [Related]
3. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Panminerva Med; 1998 Mar; 40(1):13-7. PubMed ID: 9573747
[TBL] [Abstract][Full Text] [Related]
4. GH response to GHRH combined with pyridostigmine or arginine in different conditions of low somatotrope secretion in adulthood: obesity and Cushing's syndrome in comparison with hypopituitarism.
Procopio M; Maccario M; Savio P; Valetto MR; Aimaretti G; Grottoli S; Oleandri SE; Baffoni C; Tassone F; Arvat E; Camanni F; Ghigo E
Minerva Endocrinol; 1999; 24(3-4):107-11. PubMed ID: 10953725
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.
Guzzaloni G; Grugni G; Morabito F
Minerva Endocrinol; 1998 Dec; 23(4):99-104. PubMed ID: 10361807
[TBL] [Abstract][Full Text] [Related]
6. Repeated administration of growth hormone-releasing hormone with or without previous administration of pyridostigmine in insulin-dependent diabetes mellitus.
Martina V; Bruno G; Tagliabue M; Maccario M; Bertaina S; Zumpano E; Arvat E; Ghigo E; Camanni F
Horm Metab Res; 1997 Apr; 29(4):180-3. PubMed ID: 9178028
[TBL] [Abstract][Full Text] [Related]
7. Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults.
Aimaretti G; Corneli G; Razzore P; Bellone S; Baffoni C; Arvat E; Camanni F; Ghigo E
J Clin Endocrinol Metab; 1998 May; 83(5):1615-8. PubMed ID: 9589665
[TBL] [Abstract][Full Text] [Related]
8. Reevaluation of growth hormone (GH) secretion in 69 adults diagnosed as GH-deficient patients during childhood.
Longobardi S; Merola B; Pivonello R; Di Rella F; Di Somma C; Colao A; Ghigo E; Camanni F; Lombardi G
J Clin Endocrinol Metab; 1996 Mar; 81(3):1244-7. PubMed ID: 8772606
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone.
Giusti M; Marini G; Sessarego P; Peluffo F; Valenti S; Caratti C; Giordano G
Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302
[TBL] [Abstract][Full Text] [Related]
10. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
Ghigo E; Bellone J; Aimaretti G; Bellone S; Loche S; Cappa M; Bartolotta E; Dammacco F; Camanni F
J Clin Endocrinol Metab; 1996 Sep; 81(9):3323-7. PubMed ID: 8784091
[TBL] [Abstract][Full Text] [Related]
11. Comparison of growth hormone-releasing effect of growth hormone-releasing hormone, clonidine and pyridostigmine in normal children and adolescents. GH-releasing effect of GHRH, clonidine and pyridostigmine.
Ghigo E; Arvat E; Nicolosi M; Mazza E; Camanni F
Panminerva Med; 1990; 32(1):1-3. PubMed ID: 2263395
[TBL] [Abstract][Full Text] [Related]
12. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test.
Gasperi M; Aimaretti G; Scarcello G; Corneli G; Cosci C; Arvat E; Martino E; Ghigo E
J Clin Endocrinol Metab; 1999 Aug; 84(8):2633-7. PubMed ID: 10443652
[TBL] [Abstract][Full Text] [Related]
13. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
Schmitt K; Schober E; Birnbacher R; Frisch H
Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
[TBL] [Abstract][Full Text] [Related]
14. Reproducibility of growth hormone and cortisol responses to the insulin tolerance test and the short ACTH test in normal adults.
Vestergaard P; Hoeck HC; Jakobsen PE; Laurberg P
Horm Metab Res; 1997 Mar; 29(3):106-10. PubMed ID: 9137979
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
Díez J; Iglesias P; Sastre J; Méndez J; Selgas R; Gómez-Pan A
Nephron; 1996; 74(3):548-54. PubMed ID: 8938679
[TBL] [Abstract][Full Text] [Related]
16. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
Tzanela M; Guyda H; Van Vliet G; Tannenbaum GS
J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the potentiating effect of pyridostigmine, arginine and propranolol on the GHRH-induced GH release in short children.
Bellone J; Ghigo E; Procopio M; Arvat E; Valente F; Boffano GM; Maccario M; Dentelli P; Camanni F
Panminerva Med; 1993 Mar; 35(1):1-4. PubMed ID: 8316397
[TBL] [Abstract][Full Text] [Related]
18. Effect of acute pharmacological reduction of plasma free fatty acids on growth hormone (GH) releasing hormone-induced GH secretion in obese adults with and without hypopituitarism.
Cordido F; Fernandez T; Martinez T; Peñalva A; Peinó R; Casanueva FF; Dieguez C
J Clin Endocrinol Metab; 1998 Dec; 83(12):4350-4. PubMed ID: 9851776
[TBL] [Abstract][Full Text] [Related]
19. GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults.
Popovic V; Leal A; Micic D; Koppeschaar HP; Torres E; Paramo C; Obradovic S; Dieguez C; Casanueva FF
Lancet; 2000 Sep; 356(9236):1137-42. PubMed ID: 11030292
[TBL] [Abstract][Full Text] [Related]
20. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
Ghigo E; Imperiale E; Boffano GM; Mazza E; Bellone J; Arvat E; Procopio M; Goffi S; Barreca A; Chiabotto P
J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]